Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Drechsler, Christiane ^a   Kollerits, Barbara ^b   Meinitzer, Andreas ^c   März, Winfried ^d   Ritz, Eberhard ^d   König, Paul ^e   Neyer, Ulrich ^f   Pilz, Stefan ^c,g   Wanner, Christoph ^a   Kronenberg, Florian ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f Landeskrankenhaus Feldkirch   (Austria)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HOMOARGININE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EUROPE; FEMALE; FOLLOW UP; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HOMOARGININE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEINURIA; UROGENITAL SYSTEM PARAMETERS;

ADULT; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HOMOARGININE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84877774499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063560     Document Type: Article

References (39)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047.
2. US Renal Data System (2008) USRDS 2008 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
4. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295.
5. Ryan WL, Johnson RJ, Dimari S, (1969) Homoarginine synthesis by rat kidney. Arch Biochem Biophys 131: 521-526.
6. Ryan WL, Wells IC, (1964) Homocitrulline and Homoarginine Synthesis from Lysine. Science 144: 1122-1127.
7. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, et al. (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42: 373-375.
8. Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712-717.
9. Chen PY, Sanders PW, (1993) Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22: 812-818.
10. Blachier F, Mourtada A, Sener A, Malaisse WJ, (1989) Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets. Endocrinology 124: 134-141.
11. Henningsson R, Lundquist I, (1998) Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 275: E500-506.
12. Taal MW, Brenner BM, (2006) Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int 70: 1694-1705.
13. Kronenberg F, (2009) Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 5: 677-689.
14. Kozlenkov A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, et al. (2004) Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res 19: 1862-1872.
15. Magnusson P, Farley JR, (2002) Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization. Calcif Tissue Int 71: 508-518.
16. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Dobnig H, et al. (2012) Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients. Osteoporos Int.
17. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Fahrleitner-Pammer A, et al. (2012) Homoarginine deficiency is associated with increased bone turnover. Osteoporos Int 23: 2731-2732.
18. Hrabak A, Bajor T, Temesi A, (1994) Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages. Biochem Biophys Res Commun 198: 206-212.
19. Knowles RG, Palacios M, Palmer RM, Moncada S, (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A 86: 5159-5162.
20. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, et al. (2008) Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72: 1879-1884.
21. Yang Z, Ming XF, (2006) Endothelial arginase: a new target in atherosclerosis. Curr Hypertens Rep 8: 54-59.
22. Bauersachs J, Widder JD, (2008) Endothelial dysfunction in heart failure. Pharmacol Rep 60: 119-126.
23. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, et al. (2005) Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16: 1091-1098.
24. Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F, (2007) Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 71: 1279-1286.
25. Kronenberg F, Kuen E, Ritz E, Junker R, Konig P, et al. (2000) Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 11: 105-115.
26. Meinitzer A, Puchinger M, Winklhofer-Roob BM, Rock E, Ribalta J, et al. (2007) Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 384: 141-148.
27. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA, (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303: 131-137.
28. Bostom AG, Kronenberg F, Ritz E, (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 13: 2140-2144.
29. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, et al. (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18: 2600-2608.
30. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, et al. (2006) Myocardial expression of the arginine: glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 114: I16-20.
31. Borsook H, Dubnoff JW, (1940) The Synthesis of Glycocyamine in Rat Kidney and a Mechanism of Creatine Synthesis in Vivo. Science 91: 551-552.
32. Davids M, Ndika JD, Salomons GS, Blom HJ, Teerlink T, (2012) Promiscuous activity of arginine: glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 586: 3653-3657.
33. Bell EA, (1962) The isolation of L-homoarginine from seeds of Lathyrus cicera. Biochem J 85: 91-93.
34. Rao SL, Ramachandran LK, Adiga PR, (1963) The isolation and characterization of l-homoarginine from seeds of Lathyrus sativus. Biochemistry 2: 298-300.
35. Marz W, Meinitzer A, Drechsler C, Pilz S, Krane V, et al. (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122: 967-975.
36. Tofuku Y, Muramoto H, Kuroda M, Takeda R, (1985) Impaired metabolism of guanidinoacetic acid in uremia. Nephron 41: 174-178.
37. Al Banchaabouchi M, Marescau B, Van Marck E, D'Hooge R, De Deyn PP, (2001) Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Metabolism 50: 1418-1425.
38. Radomski MW, Palmer RM, Moncada S, (1990) An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 87: 5193-5197.
39. Tangri N, Inker LA, Tighiouart H, Sorensen E, Menon V, et al. (2012) Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol. 23: 351-359.